China NMPA Product Recall - Human ABO blood typing reverse typing uses a 0.8% erythrocyte reagent kit (column agglutination method); human ABO blood typing reverse typing uses a 3% erythrocyte reagent kit (column agglutination method); human irregular antibody detection uses a 3% erythrocyte reagent kit (column agglutination method).
China NMPA product recall for Human ABO blood typing reverse typing uses a 0.8% erythrocyte reagent kit (column agglutination method); human ABO blood typing reverse typing uses a 3% erythrocyte reagent kit (column agglutination method); human irregular antibody detection uses a 3% erythrocyte reagent kit (column agglutination method). by Ortho-Clinical Diagnostics (TC2016-196) published December 29, 2016. Recall level: Level II. Ausendo Medical Devices Trading (China) Co., Ltd., on behalf of manufacturer Ortho-Clinical Diagnost
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA product recall for Human ABO blood typing reverse typing uses a 0.8% erythrocyte reagent kit (column agglutination method); human ABO blood typing reverse typing uses a 3% erythrocyte reagent kit (column agglutination method); human irregular antibody detection uses a 3% erythrocyte reagent kit (column agglutination method). by Ortho-Clinical Diagnostics (TC2016-196) published December 29, 2016. Recall level: Level II. Ausendo Medical Devices Trading (China) Co., Ltd., on behalf of manufacturer Ortho-Clinical Diagnost
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox